JP2023530264A5 - - Google Patents
Info
- Publication number
- JP2023530264A5 JP2023530264A5 JP2022575941A JP2022575941A JP2023530264A5 JP 2023530264 A5 JP2023530264 A5 JP 2023530264A5 JP 2022575941 A JP2022575941 A JP 2022575941A JP 2022575941 A JP2022575941 A JP 2022575941A JP 2023530264 A5 JP2023530264 A5 JP 2023530264A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025159926A JP2025183420A (ja) | 2020-06-11 | 2025-09-26 | 皮膚エリテマトーデスを治療するためにプレドニゾロンまたはヒドロキシクロロキンと組み合わせるｔｌｒ７阻害剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202011024586 | 2020-06-11 | ||
| IN202011024586 | 2020-06-11 | ||
| PCT/US2021/036740 WO2021252718A1 (en) | 2020-06-11 | 2021-06-10 | Tlr7 inhibitor in combination with prednisolone or hydroxychloroquine for treating cutaneous lupus erythematosus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159926A Division JP2025183420A (ja) | 2020-06-11 | 2025-09-26 | 皮膚エリテマトーデスを治療するためにプレドニゾロンまたはヒドロキシクロロキンと組み合わせるｔｌｒ７阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023530264A JP2023530264A (ja) | 2023-07-14 |
| JP2023530264A5 true JP2023530264A5 (https=) | 2024-04-30 |
| JP7751597B2 JP7751597B2 (ja) | 2025-10-08 |
Family
ID=76959055
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022575941A Active JP7751597B2 (ja) | 2020-06-11 | 2021-06-10 | 皮膚エリテマトーデスを治療するためにプレドニゾロンまたはヒドロキシクロロキンと組み合わせるｔｌｒ７阻害剤 |
| JP2025159926A Pending JP2025183420A (ja) | 2020-06-11 | 2025-09-26 | 皮膚エリテマトーデスを治療するためにプレドニゾロンまたはヒドロキシクロロキンと組み合わせるｔｌｒ７阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025159926A Pending JP2025183420A (ja) | 2020-06-11 | 2025-09-26 | 皮膚エリテマトーデスを治療するためにプレドニゾロンまたはヒドロキシクロロキンと組み合わせるｔｌｒ７阻害剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230310408A1 (https=) |
| EP (1) | EP4164639A1 (https=) |
| JP (2) | JP7751597B2 (https=) |
| KR (1) | KR20230023717A (https=) |
| CN (1) | CN115701995A (https=) |
| AU (1) | AU2021286582A1 (https=) |
| BR (1) | BR112022024999A2 (https=) |
| CA (1) | CA3181964A1 (https=) |
| IL (1) | IL298667A (https=) |
| MX (1) | MX2022015760A (https=) |
| WO (1) | WO2021252718A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230171469A (ko) | 2021-04-16 | 2023-12-20 | 길리애드 사이언시즈, 인코포레이티드 | 티에노피롤 화합물 |
| EP4398989A1 (en) | 2021-09-10 | 2024-07-17 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| AU2024356361A1 (en) * | 2023-10-02 | 2026-04-02 | Bristol-Myers Squibb Company | A method of treating lupus |
| TW202535949A (zh) | 2023-12-20 | 2025-09-16 | 美商必治妥美雅史谷比公司 | 靶向IL-18受體β(IL-18RB)之抗體及相關方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060270707A1 (en) | 2005-05-24 | 2006-11-30 | Zeldis Jerome B | Methods and compositions using 4-[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione for the treatment or prevention of cutaneous lupus |
| EP2582398B1 (en) * | 2010-06-16 | 2016-04-13 | Dynavax Technologies Corporation | Methods of treatment using tlr7 and/or tlr9 inhibitors |
| AU2013203815A1 (en) * | 2010-06-16 | 2013-05-02 | Dynavax Technologies Corporation | Methods of treatment using TLR7 and/or TLR9 inhibitors |
| WO2015200094A1 (en) * | 2014-06-20 | 2015-12-30 | Baylor Research Institute | Methods and compositions for systemic lupus erythematosus (sle) therapy |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
-
2021
- 2021-06-10 KR KR1020237000739A patent/KR20230023717A/ko active Pending
- 2021-06-10 CN CN202180040836.2A patent/CN115701995A/zh active Pending
- 2021-06-10 WO PCT/US2021/036740 patent/WO2021252718A1/en not_active Ceased
- 2021-06-10 MX MX2022015760A patent/MX2022015760A/es unknown
- 2021-06-10 EP EP21742945.5A patent/EP4164639A1/en active Pending
- 2021-06-10 JP JP2022575941A patent/JP7751597B2/ja active Active
- 2021-06-10 US US18/009,035 patent/US20230310408A1/en active Pending
- 2021-06-10 AU AU2021286582A patent/AU2021286582A1/en active Pending
- 2021-06-10 CA CA3181964A patent/CA3181964A1/en active Pending
- 2021-06-10 BR BR112022024999A patent/BR112022024999A2/pt unknown
- 2021-06-10 IL IL298667A patent/IL298667A/en unknown
-
2025
- 2025-09-26 JP JP2025159926A patent/JP2025183420A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530264A5 (https=) | ||
| JP2024133475A5 (https=) | ||
| JP2007536311A5 (https=) | ||
| CN114641293A (zh) | 一种fgfr抑制剂的用途 | |
| Pereira et al. | Effect of preemptive analgesia with ibuprofen in the control of postoperative pain in dental implant surgeries: a randomized, triple-blind controlled clinical trial | |
| JP2016106150A5 (https=) | ||
| RU2018133158A (ru) | Способы применения агонистов fxr | |
| JP2020530831A5 (https=) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2024511973A5 (https=) | ||
| JP2023533464A5 (https=) | ||
| JP2015532296A5 (https=) | ||
| JP2019530706A5 (https=) | ||
| JP2017533220A5 (https=) | ||
| JP2020500864A5 (https=) | ||
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| JP2020516663A5 (https=) | ||
| FI3706724T3 (fi) | Suun kautta otettavia rifamysiini sv -koostumuksia | |
| JP2023531675A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2016505050A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| JP2021527062A5 (https=) | ||
| JP2018506533A5 (https=) | ||
| JP2023501781A5 (https=) |